Remgro should know better. If the JSE’s largest investment company is serious about restructuring its portfolio to close a frustrating market discount, then perhaps it should not be pitching opportunistic buyout offers to minority shareholders in Mediclinic International.
But if a deal eventually does come off, Remgro will be taking a huge step towards reinventing itself as a compelling hub of top-quality unlisted investments...A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Remgro’s Mediclinic blunderThe Rupert-controlled investment company wants to reinvent itself, but not everyone is impressed.
Source: FinancialMail - 🏆 20. / 63 Read more »
Remgro’s Mediclinic blunderThe Rupert-controlled investment company wants to reinvent itself, but not everyone is impressed
Source: FinancialMail - 🏆 20. / 63 Read more »